CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating activities
Net income	$ 1,115	$ 2,151
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	4,307	4,253
Amortization of deferred financing costs charged to interest expense	457	642
Stock-based compensation expense	193	620
Deferred taxes, net	780	(6)
Changes in operating assets and liabilities:
Accounts receivable	(14,421)	3,542
Other assets	(661)	510
Accounts payable and accrued liabilities	(6,567)	(7,397)
Accrued payroll	2,275	1,909
Other liabilities	984	(1,153)
Net cash (used in) provided by operating activities	(11,538)	5,071
Investing activities
Purchase of equipment and improvements	(552)	(174)
Net cash used in investing activities	(552)	(174)
Financing activities
Proceeds from revolving line of credit	59,910	69,831
Repayment of revolving line of credit	(47,509)	(64,026)
Repayments of debt obligations	0	(10,378)
Payments of deferred financing costs	(202)	0
Proceeds from issuance of common stock upon exercise of options and warrants	0	261
Payment of tax obligations resulting from net exercise of stock options	0	(669)
Net cash provided by (used in) financing activities	12,199	(4,981)
Net change in cash	109	(84)
Cash - beginning of period	342	215
Cash - end of period	451	131
Supplemental disclosure of cash flow information
Cash paid during the period for interest	3,594	3,972
Cash paid during the period for income taxes	32	0
Common stock surrendered for the exercise of stock options	0	244
Lease liability recognized to acquire a right of use asset	$ 1,377	$ 0